EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) traded up 22.7% on Tuesday . The stock traded as high as $0.2699 and last traded at $0.2699. Approximately 120 shares were traded during trading, a decline of 99% from the average daily volume of 9,253 shares. The stock had previously closed at $0.22.
EOM Pharmaceutical Trading Up 22.7%
The stock’s 50-day moving average price is $0.15 and its 200-day moving average price is $0.15.
EOM Pharmaceutical Company Profile
EOM Pharmaceutical, trading under the ticker OTCMKTS:IMUC, is a clinical-stage biotechnology company focused on the development of cell-based immunotherapies for the treatment of solid tumors. The company leverages dendritic cell technology to create personalized therapeutic vaccines designed to activate a patient’s immune system against tumor-specific antigens. By harnessing key insights into antigen presentation and T-cell activation, EOM Pharmaceutical aims to improve survival outcomes for patients with cancers that currently have limited treatment options.
The company’s lead programs are directed at glioblastoma multiforme and other aggressive tumor types, where standard therapies often fall short.
Featured Articles
- Five stocks we like better than EOM Pharmaceutical
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for EOM Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
